To directly investigate the functional role of OX-40 in CTCL progression, we utilized CRISPR/cas9 technology to generate OX-40 knockout CTCL cell lines. This evidence concerns the gene TNFRSF4 and primary cutaneous T-cell non-Hodgkin lymphoma.